Lyophilized Cytoxan

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 21 USDMF, 6 CEP/COS, 5 EU WC, 17 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

363 Drugs in Development

363 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

145 FDF Dossiers, 85 FDA Orange Book, 15 Europe, 8 Canada, 9 Australia, 6 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG, SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML), SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML), SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 18 SPI Pharma, 7 DKSH, 4 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 20 Kerry, 3 Lonza Capsugel, 11 Microlex e.U, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 17 Roquette, 2 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 24 Direct Compression, 16 Chewable & Orodispersible Aids, 16 Thickeners and Stabilizers, 15 Taste Masking, 14 Co-Processed Excipients, 14 Lubricants & Glidants, 12 Disintegrants & Superdisintegrants, 12 Granulation, 9 Coating Systems & Additives, 8 Empty Capsules, 6 Parenteral, 5 Film Formers & Plasticizers, 4 Controlled & Modified Release, 3 Solubilizers, 3 Coloring Agents, 3 Topical, 3 Emulsifying Agents, 1 API Stability Enhancers, 1 Rheology Modifiers

DIGITAL CONTENT

71 News #PharmaBuzz

71 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 Regulatory FDF Prices

11 Regulatory FDF Prices

MARKET PLACE

14 APIs, 18 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 6 Others

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Nexus Wins Patent Litigation for Injectable Cyclophosphamide

28 May 2025

// BUSINESSWIRE

Genentech’s Polivy Combo is New Standard for Untreated Lymphoma

09 Dec 2024

// BUSINESSWIRE

Fate Therapeutics Reports Q2 2024 Results And Business Updates

13 Aug 2024

// GLOBENEWSWIRE

Enforcement Report - Week of April 10, 2024

10 Apr 2024

// FDA

Fresenius Kabi Further Expands Oncology Portfolio

28 Feb 2024

// BUSINESSWIRE

Panbela Announces Publication of Clinical Data Titled: Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan

18 Jan 2024

// GLOBENEWSWIRE

Lyophilized Cytoxan

Lyophilized Cytoxan

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers

21 USDMF

6 CEP/COS

5 EU WC

17 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

363 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

145 FDF Dossiers

85 FDA Orange Book

15 Europe

8 Canada

9 Australia

6 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG

SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML)

SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML)

SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Rochem International Inc

18 SPI Pharma

7 DKSH

4 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

4 ACG Worldwide

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

20 Kerry

3 Lonza Capsugel

11 Microlex e.U

2 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qualicaps

17 Roquette

2 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders

24 Direct Compression

16 Chewable & Orodispersible Aids

16 Thickeners and Stabilizers

15 Taste Masking

14 Co-Processed Excipients

14 Lubricants & Glidants

12 Disintegrants & Superdisintegrants

12 Granulation

INJECTABLE;INJECTION - 100MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 200MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons